ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.4001+15A>G

gnomAD frequency: 0.00004  dbSNP: rs202176821
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color Diagnostics, LLC DBA Color Health RCV000581529 SCV000690427 likely benign Hereditary cancer-predisposing syndrome 2016-07-12 criteria provided, single submitter clinical testing
GeneDx RCV001613388 SCV001833482 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002061860 SCV002368712 likely benign Hereditary nonpolyposis colorectal neoplasms 2025-01-29 criteria provided, single submitter clinical testing
Ambry Genetics RCV000581529 SCV004849131 uncertain significance Hereditary cancer-predisposing syndrome 2015-06-11 criteria provided, single submitter clinical testing The c.4001+15A>G intronic alteration consists of a A to G substitution 5 nucleotides after coding exon 9 in the MSH6 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Clinical Genetics, Academic Medical Center RCV001613388 SCV002034375 likely benign not provided no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV001613388 SCV002035570 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.